ASX - By Stock
|
NOX |
Veyonda MOA animation
|
|
RBx
|
0 |
371 |
3 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
0
|
371
|
3
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Veyonda Awarded First Allowed Patent Application
|
|
RBx
|
13 |
6.8K |
15 |
17/03/20 |
17/03/20 |
ASX - By Stock
|
13
|
6.8K
|
15
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Veyonda Clinical Program Update and Guidance
|
|
RBx
|
2 |
1.5K |
5 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
2
|
1.5K
|
5
|
|
ASX - By Stock
|
NOX |
Patent Update
|
|
RBx
|
2 |
1.2K |
4 |
04/03/20 |
04/03/20 |
ASX - By Stock
|
2
|
1.2K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Featured Interview
|
|
RBx
|
4 |
1.5K |
7 |
04/03/20 |
04/03/20 |
ASX - By Stock
|
4
|
1.5K
|
7
|
|
ASX - By Stock
|
NOX |
Re:
Featured Interview
|
|
RBx
|
4 |
1.5K |
3 |
04/03/20 |
04/03/20 |
ASX - By Stock
|
4
|
1.5K
|
3
|
|
ASX - By Stock
|
NOX |
Featured Interview
|
|
RBx
|
4 |
1.5K |
3 |
04/03/20 |
04/03/20 |
ASX - By Stock
|
4
|
1.5K
|
3
|
|
ASX - By Stock
|
NOX |
LIPROSE technology
|
|
RBx
|
0 |
2.2K |
5 |
03/03/20 |
03/03/20 |
ASX - By Stock
|
0
|
2.2K
|
5
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Half Year Accounts and Chairman Letter
|
|
RBx
|
24 |
724K |
8 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
24
|
724K
|
8
|
|
ASX - By Stock
|
NOX |
Dr Gisela Mautner interview re LuPIN data
|
|
RBx
|
0 |
1.3K |
3 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
0
|
1.3K
|
3
|
|
ASX - By Stock
|
NOX |
GenesisCare Implications
|
|
RBx
|
1 |
4.3K |
16 |
22/02/20 |
22/02/20 |
ASX - By Stock
|
1
|
4.3K
|
16
|
|
ASX - By Stock
|
NOX |
Non-dilutive finance
|
|
RBx
|
6 |
6.3K |
7 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
6
|
6.3K
|
7
|
|
ASX - By Stock
|
NOX |
CEO Blog
|
|
RBx
|
0 |
305 |
3 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
0
|
305
|
3
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Alliance With GenesisCare
|
|
RBx
|
8 |
4.1K |
7 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
8
|
4.1K
|
7
|
|
ASX - By Stock
|
NOX |
Re:
Ann: $8.1M Financing & Re-Set of Capital Structure
|
|
RBx
|
15 |
6.7K |
2 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
15
|
6.7K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Pronounced survival benefit in LuPIN interim trial data
|
|
RBx
|
11 |
3.7K |
2 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
11
|
3.7K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: $8.1M Financing & Re-Set of Capital Structure
|
|
RBx
|
15 |
6.7K |
3 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
15
|
6.7K
|
3
|
|
ASX - By Stock
|
NOX |
Brilliant!
|
|
RBx
|
2 |
1.1K |
14 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
2
|
1.1K
|
14
|
|
ASX - By Stock
|
NOX |
Rumours
|
|
RBx
|
2 |
2.7K |
3 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
2
|
2.7K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Trading Halt
|
|
RBx
|
11 |
6.5K |
1 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
11
|
6.5K
|
1
|
|
ASX - By Stock
|
NOX |
LuPIN implications
|
|
RBx
|
1 |
489 |
5 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
1
|
489
|
5
|
|
ASX - By Stock
|
NYR |
PCSK9 animation
|
|
RBx
|
1 |
1.5K |
6 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
1
|
1.5K
|
6
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Significant advance in Nyrada PCSK9i program published
|
|
RBx
|
4 |
6.9K |
11 |
11/02/20 |
11/02/20 |
ASX - By Stock
|
4
|
6.9K
|
11
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Dec 2019 Appendix 4C
|
|
RBx
|
1 |
1.9K |
7 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
1
|
1.9K
|
7
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Non-Deal Roadshow Presentation
|
|
RBx
|
4 |
2.6K |
3 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
4
|
2.6K
|
3
|
|
ASX - By Stock
|
NYR |
Brain Injury
|
|
RBx
|
0 |
897 |
10 |
25/01/20 |
25/01/20 |
ASX - By Stock
|
0
|
897
|
10
|
|
ASX - By Stock
|
NYR |
Looking ahead
|
|
RBx
|
0 |
747 |
7 |
17/01/20 |
17/01/20 |
ASX - By Stock
|
0
|
747
|
7
|
|
ASX - By Stock
|
NYR |
The worm turns?
|
|
RBx
|
4 |
1.4K |
3 |
15/01/20 |
15/01/20 |
ASX - By Stock
|
4
|
1.4K
|
3
|
|
ASX - By Stock
|
NOX |
The worm turns?
|
|
RBx
|
2 |
2.4K |
4 |
15/01/20 |
15/01/20 |
ASX - By Stock
|
2
|
2.4K
|
4
|
|
ASX - By Stock
|
NYR |
Nyrada publications
|
|
RBx
|
0 |
300 |
4 |
14/01/20 |
14/01/20 |
ASX - By Stock
|
0
|
300
|
4
|
|
ASX - By Stock
|
NYR |
Re:
NYR listing date
|
|
RBx
|
10 |
3.9K |
4 |
12/01/20 |
12/01/20 |
ASX - By Stock
|
10
|
3.9K
|
4
|
|
ASX - By Stock
|
NYR |
Re:
NYR listing date
|
|
RBx
|
10 |
3.9K |
3 |
10/01/20 |
10/01/20 |
ASX - By Stock
|
10
|
3.9K
|
3
|
|
ASX - By Stock
|
NOX |
Nyrada Listing
|
|
RBx
|
0 |
800 |
4 |
10/01/20 |
10/01/20 |
ASX - By Stock
|
0
|
800
|
4
|
|
ASX - By Stock
|
NOX |
Patent progress
|
|
RBx
|
2 |
1.2K |
5 |
10/01/20 |
10/01/20 |
ASX - By Stock
|
2
|
1.2K
|
5
|
|
ASX - By Stock
|
NYR |
NYR listing date
|
|
RBx
|
10 |
3.9K |
11 |
03/01/20 |
03/01/20 |
ASX - By Stock
|
10
|
3.9K
|
11
|
|
ASX - By Stock
|
NOX |
Inexplicable
|
|
RBx
|
4 |
3.3K |
4 |
31/12/19 |
31/12/19 |
ASX - By Stock
|
4
|
3.3K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
DARRT video animation
|
|
RBx
|
4 |
2.2K |
8 |
24/12/19 |
24/12/19 |
ASX - By Stock
|
4
|
2.2K
|
8
|
|
ASX - By Stock
|
NOX |
DARRT video animation
|
|
RBx
|
4 |
2.2K |
0 |
24/12/19 |
24/12/19 |
ASX - By Stock
|
4
|
2.2K
|
0
|
|
ASX - By Stock
|
NOX |
LuPIN
|
|
RBx
|
1 |
1.0K |
10 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
1
|
1.0K
|
10
|
|
ASX - By Stock
|
NOX |
Re:
Nyrada IPO
|
|
RBx
|
3 |
3.5K |
2 |
17/12/19 |
17/12/19 |
ASX - By Stock
|
3
|
3.5K
|
2
|
|
ASX - By Stock
|
NOX |
Nyrada IPO
|
|
RBx
|
3 |
3.5K |
7 |
16/12/19 |
16/12/19 |
ASX - By Stock
|
3
|
3.5K
|
7
|
|
ASX - By Stock
|
NOX |
Survival trumps shrinkage
|
|
RBx
|
0 |
362 |
13 |
16/12/19 |
16/12/19 |
ASX - By Stock
|
0
|
362
|
13
|
|
ASX - By Stock
|
NOX |
Prospects
|
|
RBx
|
2 |
2.2K |
12 |
05/12/19 |
05/12/19 |
ASX - By Stock
|
2
|
2.2K
|
12
|
|
ASX - By Stock
|
NOX |
Nyrada
|
|
RBx
|
0 |
1.0K |
7 |
30/11/19 |
30/11/19 |
ASX - By Stock
|
0
|
1.0K
|
7
|
|
ASX - By Stock
|
NOX |
Trading Halt
|
|
RBx
|
0 |
388 |
13 |
28/11/19 |
28/11/19 |
ASX - By Stock
|
0
|
388
|
13
|
|
ASX - By Stock
|
KZA |
Pivotal Trial
|
|
RBx
|
3 |
3.1K |
3 |
25/11/19 |
25/11/19 |
ASX - By Stock
|
3
|
3.1K
|
3
|
|
ASX - By Stock
|
NOX |
AGM Report
|
|
RBx
|
0 |
402 |
8 |
21/11/19 |
21/11/19 |
ASX - By Stock
|
0
|
402
|
8
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Appendix 3B cleansing statement and disclosures
|
|
RBx
|
46 |
15K |
4 |
01/11/19 |
01/11/19 |
ASX - By Stock
|
46
|
15K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Appendix 3B cleansing statement and disclosures
|
|
RBx
|
46 |
15K |
3 |
01/11/19 |
01/11/19 |
ASX - By Stock
|
46
|
15K
|
3
|
|
ASX - By Stock
|
NOX |
Looking Good
|
|
RBx
|
0 |
380 |
7 |
30/10/19 |
30/10/19 |
ASX - By Stock
|
0
|
380
|
7
|
|